Home > Investor Relations > Financials & Filings Financials & Filings Second Quarter 2018 Financial Results Show all 2018 Second Quarter NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash Guidance Second Quarter 2018 Earnings Conference Call Form 10-Q Proxy Statements Filing date View Apr 9, 2018 View HTML 0001126234-18-000064.pdf 0001126234-18-000064.xls Mar 31, 2017 View HTML 0001126234-17-000030.pdf 0001126234-17-000030.xls Form 10-K Filing date View Mar 5, 2018 View HTML 0001126234-18-000026.pdf 0001126234-18-000026.xls Mar 6, 2017 View HTML 0001126234-17-000025.pdf 0001126234-17-000025.xls Form 10-Q Filing date View Nov 2, 2018 View HTML 0001126234-18-000140.pdf 0001126234-18-000140.xls Aug 6, 2018 View HTML 0001126234-18-000123.pdf 0001126234-18-000123.xls Facebook Google LinkedIn Twitter RSS
Financials & Filings Second Quarter 2018 Financial Results Show all 2018 Second Quarter NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash Guidance Second Quarter 2018 Earnings Conference Call Form 10-Q Proxy Statements Filing date View Apr 9, 2018 View HTML 0001126234-18-000064.pdf 0001126234-18-000064.xls Mar 31, 2017 View HTML 0001126234-17-000030.pdf 0001126234-17-000030.xls Form 10-K Filing date View Mar 5, 2018 View HTML 0001126234-18-000026.pdf 0001126234-18-000026.xls Mar 6, 2017 View HTML 0001126234-17-000025.pdf 0001126234-17-000025.xls Form 10-Q Filing date View Nov 2, 2018 View HTML 0001126234-18-000140.pdf 0001126234-18-000140.xls Aug 6, 2018 View HTML 0001126234-18-000123.pdf 0001126234-18-000123.xls
Contact us
Contact us